Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

Cited In for PubMed (Select 21292718)

1.

Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada.

Hinds AM, Bozat-Emre S, Van Caeseele P, Mahmud SM.

BMC Public Health. 2015 Jan 30;15:35. doi: 10.1186/s12889-015-1351-z.

2.

Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.

Sullivan SG, Feng S, Cowling BJ.

Expert Rev Vaccines. 2014 Dec;13(12):1571-91. doi: 10.1586/14760584.2014.966695. Epub 2014 Oct 28.

PMID:
25348015
3.

Influenza vaccines: a moving interdisciplinary field.

Schotsaert M, García-Sastre A.

Viruses. 2014 Oct 9;6(10):3809-26. doi: 10.3390/v6103809.

4.

Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland.

Syrjänen RK, Jokinen J, Ziegler T, Sundman J, Lahdenkari M, Julkunen I, Kilpi TM.

PLoS One. 2014 Sep 29;9(9):e108538. doi: 10.1371/journal.pone.0108538. eCollection 2014.

5.

Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec.

Montplaisir J, Petit D, Quinn MJ, Ouakki M, Deceuninck G, Desautels A, Mignot E, De Wals P.

PLoS One. 2014 Sep 29;9(9):e108489. doi: 10.1371/journal.pone.0108489. eCollection 2014.

6.

Geographical heterogeneity and influenza infection within households.

Chao DY, Cheng KF, Hsieh YH, Li TC, Wu TN, Chen CY.

BMC Infect Dis. 2014 Jul 3;14:369. doi: 10.1186/1471-2334-14-369.

7.

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.

Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter AL, Gubbay JB, Krajden M, Petric M, Charest H, Bastien N, Kwindt TL, Mahmud SM, Van Caeseele P, Li Y.

PLoS One. 2014 Mar 25;9(3):e92153. doi: 10.1371/journal.pone.0092153. eCollection 2014.

8.

Relative efficacy of AS03-adjuvanted pandemic influenza A(H1N1) vaccine in children: results of a controlled, randomized efficacy trial.

Nolan T, Roy-Ghanta S, Montellano M, Weckx L, Ulloa-Gutierrez R, Lazcano-Ponce E, Kerdpanich A, Safadi MA, Cruz-Valdez A, Litao S, Lim FS, de Los Santos AM, Weber MA, Tinoco JC, Mezerville MH, Faingezicht I, Kosuwon P, Lopez P, Borja-Tabora C, Li P, Durviaux S, Fries L, Dubin G, Breuer T, Innis BL, Vaughn DW.

J Infect Dis. 2014 Aug 15;210(4):545-57. doi: 10.1093/infdis/jiu173. Epub 2014 Mar 20.

9.

Effectiveness of neuraminidase inhibitors in preventing hospitalization during the H1N1 influenza pandemic in British Columbia, Canada.

Marra F, Chong M, Henry B, Patrick DM, Kendall P.

J Antimicrob Chemother. 2014 May;69(5):1397-406. doi: 10.1093/jac/dkt496. Epub 2013 Dec 16.

10.

Patterns of spread of influenza A in Canada.

He D, Dushoff J, Eftimie R, Earn DJ.

Proc Biol Sci. 2013 Sep 11;280(1770):20131174. doi: 10.1098/rspb.2013.1174. Print 2013 Nov 7.

11.

Mandatory vaccination.

Van Buynder PG, Bryce E, Henry B, Kendall PR.

CMAJ. 2013 Aug 6;185(11):983. doi: 10.1503/cmaj.113-2123. No abstract available.

12.

Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study.

Cheng AC, Holmes M, Irving LB, Brown SG, Waterer GW, Korman TM, Friedman ND, Senanayake S, Dwyer DE, Brady S, Simpson G, Wood-Baker R, Upham J, Paterson D, Jenkins C, Wark P, Kelly PM, Kotsimbos T.

PLoS One. 2013 Jul 16;8(7):e68760. doi: 10.1371/journal.pone.0068760. Print 2013.

13.
14.

Effectiveness of MF59™ adjuvanted influenza A(H1N1)pdm09 vaccine in risk groups in the Netherlands.

Wijnans L, Dieleman J, Voordouw B, Sturkenboom M.

PLoS One. 2013 Apr 30;8(4):e63156. doi: 10.1371/journal.pone.0063156. Print 2013.

15.

Influenza vaccine effectiveness in the community and the household.

Ohmit SE, Petrie JG, Malosh RE, Cowling BJ, Thompson MG, Shay DK, Monto AS.

Clin Infect Dis. 2013 May;56(10):1363-9. doi: 10.1093/cid/cit060. Epub 2013 Feb 14.

16.

Estimating the influenza vaccine effectiveness against medically attended influenza in clinical settings: a hospital-based case-control study with a rapid diagnostic test in Japan.

Suzuki M, Yoshimine H, Harada Y, Tsuchiya N, Shimada I, Ariyoshi K, Inoue K.

PLoS One. 2013;8(1):e52103. doi: 10.1371/journal.pone.0052103. Epub 2013 Jan 11.

17.

Nanoemulsion nasal adjuvant W₈₀5EC induces dendritic cell engulfment of antigen-primed epithelial cells.

Myc A, Kukowska-Latallo JF, Smith DM, Passmore C, Pham T, Wong P, Bielinska AU, Baker JR Jr.

Vaccine. 2013 Feb 4;31(7):1072-9. doi: 10.1016/j.vaccine.2012.12.033. Epub 2012 Dec 25.

19.

Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.

Hellenbrand W, Jorgensen P, Schweiger B, Falkenhorst G, Nachtnebel M, Greutélaers B, Traeder C, Wichmann O.

BMC Infect Dis. 2012 May 31;12:127. doi: 10.1186/1471-2334-12-127.

20.

Two years after pandemic influenza A/2009/H1N1: what have we learned?

Cheng VC, To KK, Tse H, Hung IF, Yuen KY.

Clin Microbiol Rev. 2012 Apr;25(2):223-63. doi: 10.1128/CMR.05012-11. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk